rs374450869
Variant names: 
Your query was ambiguous. Multiple possible variants found: 
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6
The NM_014845.6(FIG4):c.2376+9G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000026 in 1,613,312 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
 Genomes: 𝑓 0.00011   (  0   hom.,  cov: 33) 
 Exomes 𝑓:  0.000017   (  0   hom.  ) 
Consequence
 FIG4
NM_014845.6 intron
NM_014845.6 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  0.0670  
Publications
0 publications found 
Genes affected
 FIG4  (HGNC:16873):  (FIG4 phosphoinositide 5-phosphatase) The protein encoded by this gene belongs to the SAC domain-containing protein gene family. The SAC domain, approximately 400 amino acids in length and consisting of seven conserved motifs, has been shown to possess phosphoinositide phosphatase activity. The yeast homolog, Sac1p, is involved in the regulation of various phosphoinositides, and affects diverse cellular functions such as actin cytoskeleton organization, Golgi function, and maintenance of vacuole morphology. Membrane-bound phosphoinositides function as signaling molecules and play a key role in vesicle trafficking in eukaryotic cells. Mutations in this gene have been associated with Charcot-Marie-Tooth disease, type 4J. [provided by RefSeq, Jul 2008] 
FIG4 Gene-Disease associations (from GenCC):
- Charcot-Marie-Tooth diseaseInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen, Illumina
- Charcot-Marie-Tooth disease type 4JInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, Laboratory for Molecular Medicine
- Yunis-Varon syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P
- amyotrophic lateral sclerosis type 11Inheritance: Unknown, AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Genomics England PanelApp
- amyotrophic lateral sclerosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- bilateral parasagittal parieto-occipital polymicrogyriaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -5 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7). 
BP6
Variant 6-109791580-G-A is Benign according to our data. Variant chr6-109791580-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 447334.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.000112  AC: 17AN: 152200Hom.:  0  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
17
AN: 
152200
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.0000641  AC: 16AN: 249498 AF XY:  0.0000740   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
16
AN: 
249498
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.0000171  AC: 25AN: 1460994Hom.:  0  Cov.: 31 AF XY:  0.0000165  AC XY: 12AN XY: 726806 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
25
AN: 
1460994
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
12
AN XY: 
726806
show subpopulations 
African (AFR) 
 AF: 
AC: 
9
AN: 
33472
American (AMR) 
 AF: 
AC: 
3
AN: 
44714
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26130
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39696
South Asian (SAS) 
 AF: 
AC: 
6
AN: 
86236
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
53076
Middle Eastern (MID) 
 AF: 
AC: 
1
AN: 
5736
European-Non Finnish (NFE) 
 AF: 
AC: 
5
AN: 
1111576
Other (OTH) 
 AF: 
AC: 
1
AN: 
60358
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.483 
Heterozygous variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.000112  AC: 17AN: 152318Hom.:  0  Cov.: 33 AF XY:  0.0000805  AC XY: 6AN XY: 74492 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
17
AN: 
152318
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
6
AN XY: 
74492
show subpopulations 
African (AFR) 
 AF: 
AC: 
14
AN: 
41570
American (AMR) 
 AF: 
AC: 
1
AN: 
15306
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3468
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5172
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4824
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10626
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
1
AN: 
68032
Other (OTH) 
 AF: 
AC: 
1
AN: 
2114
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.499 
Heterozygous variant carriers
 0 
 2 
 3 
 5 
 6 
 8 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
ClinVar
Significance: Conflicting classifications of pathogenicity 
Submissions summary: Uncertain:1Benign:1 
Revision: criteria provided, conflicting classifications
LINK: link 
Submissions by phenotype
not specified    Uncertain:1 
Sep 19, 2016
Athena Diagnostics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Charcot-Marie-Tooth disease type 4    Benign:1 
Jun 01, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.